Stay up to date on recent advances in the multidisciplinary approach to cancer.
Outpatient Robotic Partial Nephrectomy Is Safe/Feasible for Renal Tumors
A prospective trial established that 97% of patients were successfully discharged on the same day as receiving robotic partial nephrectomy.
Elucidating Non-Invasive Radiosurgery Advancements in CNS Tumors
A dedicated, well-trained, and expert staff at the Ivy Brain Tumor Center enables the facility to be at the forefront of cutting-edge radiosurgery treatment.
Hypofractionated RT Shows Portal Vein Tumor Thrombosis Control, OS in HCC
Ten-fraction image-guided hypofractionated radiation therapy could be a feasible treatment option for portal vein tumor thrombosis in patients with HCC.
Eliminating Racial Disparities in Guideline-Concordant Breast Cancer Care
Findings highlight a need to incorporate diverse populations when developing guideline-concordant breast cancer care to achieve efficacy for all patients.
Zanidatamab Recommended For Conditional Marketing Approval in Advanced HER2+ BTC
The recommendation from the CHMP is based on results from the phase 2b HERIZON-BTC-01 trial of zanidatamab in advanced HER2+ biliary tract cancer.
Low-Dose CT Screening for Lung Cancer Shows Large-Scale Efficacy
Study data show a small number of individuals with a lung cancer diagnosis within 12 months of a negative baseline screening result.
![“[O]ur findings show that large-scale lung cancer screening is both feasible and effective, and provide a framework for successful delivery of a population-based national program,” according to the study authors.](/_next/image?url=https%3A%2F%2Fcdn.sanity.io%2Fimages%2F0vv8moc6%2Fcancernetwork%2F555f5be80532573a6654f0b562c43e11aedf99df-1200x857.jpg%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "“[O]ur findings show that large-scale lung cancer screening is both feasible and effective, and provide a framework for successful delivery of a population-based national program,” according to the study authors.")
